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Abstract Focal adhesion kinase (FAK) is a key mediator of
integrin signaling, which has been implicated in the regulation of
cell migration and cell cycle progression. Using chimeric
molecules that fuse the focal adhesion targeting (FAT) sequence
directly to several signaling molecules, we investigated the
potential role of FAK recruitments of signaling molecules to
focal contacts in the regulation of cell migration and cell cycle
progression. We found that fusion of FAT to Src, the p85 subunit
of phosphatidylinositol 3-kinase, Grb7 and Grb2 resulted in the
efficient focal adhesion targeting of these signaling molecules.
We showed that expression of Src-FAT, p85-FAT, or Grb7-
FAT, but not Grb2-FAT, each stimulated cell migration.
Interestingly, tyrosine phosphorylation of paxillin, but not
p130cas, was induced by expression of Src-FAT, suggesting a
potential role of paxillin in mediating stimulation of cell
migration by the chimeric molecule. In contrast, targeting of
Grb2, but not Src, p85, or Grb7, to focal contacts increased cell
cycle progression. Biochemical analyses correlated Erk activa-
tion by Grb2-FAT with its stimulation of cell cycle progression.
Together, these results suggest that at least part of the role of
FAK interaction with these signaling molecules is to recruit them
to focal contacts and that distinct FAK signaling complexes are
involved in the regulation of cell migration vs. cell cycle
progression. ß 2001 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine ki-
nase that has been implicated in integrin-mediated signal
transduction pathways [1^4]. In adherent cells, FAK colocal-
izes with integrins in focal adhesions. FAK activation and
tyrosine phosphorylation have been shown in a variety of
cell types to be dependent on integrins binding to their extra-
cellular ligands [2]. Integrin signaling through FAK has been
proposed to play a role in the regulation of integrin-mediated
cell migration. Increased endothelial cell migration into
wounded monolayer was correlated with increased tyrosine
phosphorylation and kinase activity of FAK [5], and the rapid
migration of keratinocytes in epidermal wound healing was
shown to coincide with FAK expression in the migrating cells
[6]. Furthermore, FAK3/3 ¢broblasts derived from FAK
knockout mouse embryos showed a signi¢cant decrease in
cell migration compared with the cells from wild-type mice.
The defects in cell migration have been suggested to be re-
sponsible for the general mesodermal de¢ciency and embry-
onic lethal phenotype of the knockout mice [7]. Similarly, in-
hibition of FAK by the FAK C-terminal recombinant protein
(i.e. FRNK) caused decreased motility of both ¢broblasts and
endothelial cells [8] as well as a reduced rate of ¢broblast
spreading [9]. Lastly, overexpression of FAK in a number
of cell lines including the FAK3/3 cells promoted their mi-
gration on ¢bronectin (FN) [10^12].
Recent studies also suggested a role for FAK and its asso-
ciated signaling pathways in the regulation of cell survival and
cell cycle progression. Expression of a membrane-anchored
FAK that is constitutively active in suspended cells prevented
cell detachment-induced apoptosis of MDCK cells [13]. Con-
versely, inhibition of FAK by either treatment of tumor cell
lines with FAK antisense oligonucleotides [14] or by micro-
injection of CEF cells with an anti-FAK monoclonal antibody
[15] induced apoptosis. In addition, microinjection of the C-
terminal fragment of FAK into either ¢broblasts or endothe-
lial cells decreased their DNA synthesis [8]. Disruption of FN
matrix assembly by treating cells with FN fragments sup-
pressed FAK tyrosine phosphorylation and resulted in the
delay of the G1 to S transition, suggesting a role for FAK
in cell cycle progression [16]. Using a tetracycline-regulated
expression system, we have shown recently that expression
of wild-type FAK accelerated G1 to S transition whereas ex-
pression of a dominant negative FAK mutant inhibited cell
cycle progression at the G1 phase [17].
FAK interactions with other intracellular signaling mole-
cules have been proposed to be responsible for its regulation
of cell migration and cell cycle progression, although the exact
mechanisms involved are not very clear at present. Upon its
activation, FAK is autophosphorylated at Y397 which medi-
ates FAK association with a number of SH2 (Src homology 2)
domain-containing signaling molecules including Src family
kinases [18^21], the p85 subunit of phosphatidylinositol 3-ki-
nase (PI3K) [22], phospholipase C-Q [23] and Grb7 [24]. FAK
binding to Src family kinases has been proposed to allow
phosphorylation of Y925 of FAK by Src, which binds to
the SH2 domain of Grb2 [25]. Associations of FAK with these
(and potentially other) signaling molecules may result in the
activation of the binding partners necessary for triggering
downstream signaling pathways. Alternatively, such associa-
tions may function to recruit these FAK binding molecules to
focal contacts that facilitate the downstream signaling events.
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In this paper, we investigated the role of the latter mechanism
in signal transduction by FAK by creating fusion proteins
that directly target Grb2, Src, p85, or Grb7 to focal contacts.
We found that targeting of Src, p85, or Grb7, but not Grb2,
to focal contacts each stimulated cell migration. In contrast,
targeting of Grb2, but not Src, p85, or Grb7, to focal contacts
increased cell cycle progression. These results suggest that at
least part of the role of FAK interaction with these signaling
molecules is to recruit them to focal contacts and that distinct
FAK signaling complexes are involved in the regulation of cell
migration vs. cell cycle progression.
2. Materials and methods
2.1. Reagents
Protein A-Sepharose 4B, human plasma FN, mouse monoclonal
antibody (mAb) anti-BrdU, mouse mAb anti-vinculin and Ni beads
were purchased from Sigma. Lipofectamine was purchased from Life
Technologies, Inc. The mouse mAb 12CA5, which recognizes the
hemagglutinin (HA) epitope tag, has been described previously [26].
The mouse anti-phosphotyrosine mAb PY-20 and mAb anti-paxillin
were purchased from Transduction Laboratories (Lexington, KY,
USA). The rabbit polyclonal anti-HA (HA probe), polyclonal anti-
FAK (A-17), polyclonal anti-Erk, and mouse mAb 9E10, which rec-
ognizes the c-Myc epitope tag, were obtained from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA, USA). The rabbit anti-phospho-
MAPK was from New England Biolabs, Inc. (Beverly, MA, USA).
2.2. Construction of expression vectors
The pEGFP-C3 plasmid encoding the green £uorescence protein
(GFP) was as described (Clontech, CA, USA). pKH3 and pKH3-
FAK have been described previously [27]. The pRc/CMV-Cas(Myc)
plasmid encoding Myc-tagged p130cas has been described previously
[28]. The expression vector encoding His-tagged Erk was a generous
gift of Dr. Mark Roberson (Cornell University).
The DNA segment encoding the focal adhesion targeting (FAT)
sequence of FAK (residues 890^1052 of FAK) was excised from
pEGFP-FAT [29] by digestion with SmaI and EcoRI. The sticky
end of the fragment was ¢lled in with Klenow and then inserted
into pKH3 at the SmaI site to generate pKH3-FAT. The expression
vector pEVX-cSrc encoding c-Src was a generous gift of D. Shalloway
(Cornell University). The cDNA insert was ampli¢ed from this plas-
mid by PCR using sense (5P-CGGGATCCATGGGGAGCAGCAA-
GAGC-3P) and antisense (5P-GAATTCACGTCGACAGGTTCTC-
TCCAGGCTG-3P) oligonucleotides. The PCR fragments were then
digested with BamHI and SalI. A SalI to EcoRI fragment encoding
FAT was excised from pEGFP-FAT. These two fragments were li-
gated together into pKH3 that had been digested with BamHI and
EcoRI to generate the expression vector pKH3-Src-FAT.
Similar strategies were used to create expression vectors encoding
the Grb7-FAT, p85-FAT, and Grb2-FAT chimeras. A cDNA frag-
ment encoding Grb7 was ampli¢ed from pKH3-Grb7 [24] by PCR
using sense (5P-GGAATTCATATGGAGCTGGATCTGTCTCCAC-
3P) and antisense (5P-GGTCGACAGAGGGCCACCCGCGTGC-3P)
oligonucleotides. It was then digested with EcoRI and SalI, and li-
gated together with the SalI to EcoRI fragment encoding FAT into
pKH3 that had been digested with EcoRI, resulting in the expression
vector pKH3-Grb7-FAT. A cDNA fragment encoding p85 was
ampli¢ed from pKH3-p85 [30] by PCR using sense (5P-CGGGATCC-
CATATGAGTGCTGAGGGGTACC-3P) and antisense (5P-GG-
AATTCCTCGCCTCTGCTGTGCATATACTG-3P) oligonucleotides.
A cDNA fragment encoding Grb2 was ampli¢ed from pGEX-2T-
Grb2 (generous gift of Dr. Wei Li, University of Chicago) by PCR
using sense (5P-CGGGATCCATGGAAGCCATCGCCAAATAT-
GACTTC-3P) and antisense (5P-GGAATTCCGACGTTCCGGTT-
CACGG-3P) oligonucleotides. The PCR fragments were then digested
with BamHI and EcoRI, ligated together with an EcoRI fragment
encoding FAT (excised from pEGFP-FAT) into pKH3 that had
been digested with BamHI and EcoRI, resulting in the expression
vectors pKH3-p85-FAT and pKH3-Grb2-FAT, respectively. Each
chimeric construct was con¢rmed by DNA sequencing (BioResource
Center, Cornell University).
2.3. Immuno£uorescence staining
NIH 3T3 cells were maintained in Dulbecco’s modi¢ed Eagle’s
medium (DME) supplemented with 10% calf serum (CS). They were
transfected with pKH3-Grb2-FAT, pKH3-p85-FAT, pKH3-cSrc-
FAT, or pKH3-Grb7-FAT using the LipofectAmine and PLUS1
transfection reagents (Life Technologies, Inc.) according to the man-
ufacturer’s instructions. One day after transfection, the cells were pro-
cessed for immuno£uorescence staining as described previously [29].
Brie£y, cells were plated on 18 mm coverslips that had been coated
with 10 Wg/ml human plasma ¢bronectin. They were incubated in a
37‡C incubator to allow for cell attachment and spreading. Cells were
then ¢xed with 3% formaldehyde for 15 min at room temperature,
washed three times with phosphate-bu¡ered saline (PBS), permeabi-
lized with 0.5% Triton X-100 at room temperature, and washed three
times with PBS. They were stained with polyclonal anti-HA (1:300)
and mAb anti-vinculin (1:50), or mAb anti-HA (1:100) and polyclon-
al anti-FAK (A-17) (1:100) in the presence of 10% goat serum for 1 h
at 37‡C. After washing three times with PBS, the bound primary
antibody was detected using FITC-conjugated anti-rabbit IgG
(1:150) and rhodamine-conjugated anti-mouse IgG (1:150) antibod-
ies. Images of stained cells were captured using an immuno£uores-
cence microscope and a CCD camera.
2.4. Cell migration assay
CHO cells were maintained in DME supplemented with 10% fetal
bovine serum. They were transfected with a combination of the in-
dicated expression vectors and pEGFP-C3 in a 5:1 ratio (3 Wg total
DNA) using LipofectAmine (Life Technologies, Inc.) according to the
manufacturer’s instructions. Two days after transfection, the cells
were trypsinized and washed in serum-free medium. Approximately
1U105 cells were then replated on a 60 mm tissue culture dish that
had been coated with 5 Wg/ml human plasma ¢bronectin in PBS. After
2 h incubation at 37‡C and 5% CO2, the medium was replaced with a
CO2-independent medium (Gibco BRL) supplemented with 0.1% fetal
bovine serum, and the cells were transferred into a humidi¢ed 37‡C
chamber at atmospheric CO2. A £uorescent image was captured to
detect GFP (i.e. positively transfected) cells. Time-lapse phase-con-
trast images were then captured at 15 min intervals using the Image-
Pro Plus software program v3.0 and its speci¢c cell motility macro
called OMAware (Image Acquisition and Object Motility Analysis)
v1.1 for Windows NT v4.0. These phase-contrast images were con-
verted to black and white images using OMAware and saved as JPEG
images. The OMAware program was then used to determine the ve-
locity, distance traveled and migration path for each cell based on its
centroid as determined from the cell boundaries in the JPEG images.
The mean velocity of the control (GFP3) cells was determined and
the velocity of each transfected cell (GFP) was calculated relative to
this value. Data were collected using approximately 30 positively
transfected cells in three independent assays for each expression vec-
tor.
2.5. Analysis of 5-bromodeoxyuridine incorporation
NIH 3T3 cells were transfected using the LipofectAmine and
PLUS1 transfection reagents (Life Technologies, Inc.) according to
the manufacturer’s instructions. The subcon£uent transfected cells
were serum starved for 48 h in DME with 0.5% CS. They were
then washed twice with DME and incubated for 16 h with 100 WM
5-bromodeoxyuridine (BrdU) (Sigma) in DME plus 10% CS. Cellular
DNA was digested with 0.5 U/Wl DNase I (New England Biolabs,
Inc.) for 30 min at 37‡C. Cells were then processed for double immu-
no£uorescence staining with mAb anti-BrdU (1:300) and polyclonal
anti-HA (HA probe) (1:300), as described above. About 50^100 pos-
itively transfected cells (as recognized by anti-HA) in multiple ¢elds
were scored for BrdU staining in each independent experiment.
2.6. Immunoprecipitation and Western blotting
Subcon£uent cells were washed twice with ice-cold PBS and then
lysed using ice-cold modi¢ed RIPA bu¡er (50 mM Tris pH 7.4,
150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
sodium dodecylsulfate, 5 mM EDTA, 30 mM Na2HPO4, 50 mM
NaF, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl £uoride, 10 mg/
ml aprotinin, and 20 mg/ml leupeptin), as described previously [10].
For detection of Erk activation by chimeric molecules, lysates were
prepared from cells that had been suspended by trypsinization and re-
plated on 10 Wg/ml FN for 20 min. Lysates were cleared by centrifu-
gation and total protein concentration was determined using the Bio-
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Rad protein assay (Hercules, CA, USA). Immunoprecipitations were
carried out by incubating cell lysates with appropriate antibodies for
2 h at 4‡C, followed by incubation for 1.5 h with protein A-Sepharose.
After washing, immune complexes were resolved using SDS^PAGE.
Western blotting was carried out using horseradish peroxidase-conju-
gated IgG as a secondary antibody and the Amersham ECL system
for detection.
3. Results
To investigate the role of localization of speci¢c signaling
molecules to focal contacts through their association with
FAK, we constructed expression vectors encoding chimeric
molecules that fused the FAT sequence (residues 890^1052
of FAK) to the C-terminus of Src, p85, Grb2 and Grb7
(Fig. 1). NIH 3T3 cells were transiently transfected with these
vectors, and the subcellular localization of the encoded chi-
meric proteins was examined by immuno£uorescence staining.
Fig. 2 shows that all four chimeric molecules were targeted to
focal contacts (left panels), which was veri¢ed by co-staining
of vinculin in the same cells (right panels). When transfected
into the same cells, the corresponding signaling molecules
without fusion to the FAT sequence were hardly detectable
in the focal contacts (data not shown). These results suggest
that addition of the FAT sequence was su⁄cient to target
these signaling molecules to focal contacts e⁄ciently. As ob-
served previously [8,9], the endogenous FAK was e¡ectively
competed out of the focal contacts by expression of these
chimeric molecules (Fig. 3).
We then analyzed the e¡ects of the chimeras on cell migra-
tion. CHO cells were transiently transfected with the expres-
sion vectors encoding FAK, FAT, or the chimeric molecules
together with a plasmid encoding GFP. The expression of
transfected constructs was veri¢ed by Western blotting using
anti-HA which recognized the triple HA epitope tag fused to
Fig. 1. Schematic diagram of chimeric signaling molecules Grb2-
FAT, p85-FAT, Src-FAT and Grb7-FAT.
Fig. 2. Focal contact localization of chimeric signaling molecules.
NIH 3T3 cells transfected with expression vectors encoding Grb2-
FAT, p85-FAT, Src-FAT or Grb7-FAT were plated on ¢bronectin-
coated coverslips. They were then ¢xed, permeabilized, and co-
stained with polyclonal anti-HA and mAb anti-vinculin, as indi-
cated. Representative focal contacts are marked by small white ar-
rows.
Fig. 3. Focal contact localization of chimeric signaling molecules.
NIH 3T3 cells transfected with expression vectors encoding Grb2-
FAT, p85-FAT, Src-FAT, Grb7-FAT, or mock control were plated
on ¢bronectin-coated coverslips. They were then ¢xed, permeabi-
lized, and co-stained with mAb anti-HA and polyclonal anti-FAK
(A-17 recognizing the N-terminal domain of FAK which is not
present in the chimeric molecules), as indicated. Representative focal
contacts are marked by small white arrows.
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the N-terminus of the encoded proteins (Fig. 4A). Migration
of the transfected cells on ¢bronectin was then evaluated using
the time-lapse imaging-based computerized motility analysis
method OMAware, as described previously [30]. Fig. 4B
shows that, consistent with previous results [10], expression
of FAK increased cell migration by about 35% whereas ex-
pression of FAT inhibited it by approximately 40%. Interest-
ingly, expression of the Src-FAT, p85-FAT, and Grb7-FAT
chimeras each stimulated cell migration by approximately
20% when compared with the mock-transfected cells. In con-
trast, expression of the Grb2-FAT chimera inhibited cell mi-
gration by a similar extent as the FAT alone. These results
suggested that recruitment of Src, p85, and Grb7, but not
Grb2, by FAK to focal contacts each played a role in the
regulation of cell migration.
Previous studies suggested that the FAK/Src complex
stimulated cell migration through its phosphorylation of
p130cas or paxillin [28,31] whereas the downstream targets
for the FAK/PI3K or FAK/Grb7 complexes are unknown
at present. To explore the mechanism by which the individual
chimeric molecules stimulated cell migration, we examined the
e¡ects of the chimeric molecules on the tyrosine phosphory-
lation of p130cas and paxillin. Consistent with previous re-
sults [28,31], overexpression of FAK induced tyrosine phos-
phorylation of p130cas and paxillin (Fig. 5). However, none
of the chimeric molecules caused increased tyrosine phosphor-
ylation of p130cas (Fig. 5A, B). Interestingly, expression of
Src-FAT, but not the other chimeric molecules, stimulated
tyrosine phosphorylation of paxillin (Fig. 5C, D). Together,
these results suggest that tyrosine phosphorylation of paxillin
might mediate stimulation of cell migration by the Src-FAT
chimeric molecule and that p130cas was not involved in the
regulation of cell migration by any of the chimeric molecules.
Recruitment of signaling molecules such as Src and PI3K to
focal contacts by FAK has also been suggested to play a role
in the regulation of cell cycle progression [17]. Thus, we also
examined the e¡ects of the focal contact targeted chimeric
molecules on cell cycle progression using the BrdU incorpo-
ration assays (Fig. 5A, B). As observed previously [17], ex-
pression of wild-type FAK did not have signi¢cant e¡ects on
BrdU incorporation under our experimental conditions. In
contrast, transfection of the expression vector encoding FAT
alone inhibited BrdU incorporation in these cells. This is con-
sistent with previous results that FAT could inhibit the en-
dogenous FAK functions by displacing it from focal contact
localizations (see Fig. 3). Interestingly, expression of the
Grb2-FAT chimera reversed the inhibitory e¡ects of FAT,
suggesting that targeting of Grb2 to focal contacts provided
a positive signal for cell cycle progression. Expression of the
other chimeric molecules Src-FAT, p85-FAT, or Grb7-FAT
showed similar inhibition of BrdU incorporation as FAT
under the same conditions, further highlighting the speci¢c
activities of Grb2-FAT. Consistent with these results, we
also observed that expression of Grb2-FAT, but not Src-Fig. 4. Regulation of cell migration by the chimeric molecules.
CHO cells were transfected with expression vectors encoding FAK,
FAT, Grb2-FAT, p85-FAT, Src-FAT or Grb7-FAT, or the pKH3
vector alone control (mock), as indicated. Lysates from a fraction
of the transfected cells were analyzed by Western blotting using
anti-HA (A). They were then subjected to the cell migration assays
as described in Section 2. The mean and standard deviation of rela-
tive migration rate (normalized to untransfected cells as 1.0) from
three independent experiments are shown (B).
Fig. 5. E¡ects of the chimeric molecules on tyrosine phosphoryla-
tion of p130cas and paxillin. A, B: CHO cells were transfected with
vectors encoding p130cas and FAK, FAT, or the chimeric molecules
as indicated. Cell lysates were immunoprecipitated by anti-Myc anti-
body followed by Western blotting with PY-20 (A) or anti-Myc (B).
C, D: CHO cells were transfected with expression vectors encoding
FAK, FAT, or the chimeric molecules as indicated. Cell lysates
were immunoprecipitated by anti-paxillin followed by Western blot-
ting with PY-20 (C) or anti-paxillin (D).
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FAT, p85-FAT, or Grb7-FAT, reversed inhibition of Erk
activity by FAT in cell adhesion to FN (Fig. 6B). We did
not detect any di¡erences in the JNK activities upon trans-
fection of any of the chimeric molecules (data not shown).
Together, these results suggest that recruitment of Grb2, but
not Src, PI3K, or Grb7, to focal contacts was su⁄cient for
stimulation of cell cycle progression by FAK.
4. Discussion
Focal contacts are specialized cellular structures where cells
connect the extracellular matrix (ECM) with the actin cyto-
skeleton through the transmembrane receptor integrins. Re-
cent studies have also suggested that focal contacts are sites of
multiple signal transduction pathways triggered by integrins
[2,32]. Multiple signaling molecules have been shown to local-
ize to the focal contacts upon integrins clustering by ECM
ligands or anti-integrin antibodies [33]. FAK is a tyrosine ki-
nase localized in the focal contacts, which also become asso-
ciated with a variety of other signaling molecules such as Src
family kinases, PI3K, Grb2 and Grb7 [1,3,4]. Association of
FAK with these signaling molecules has been proposed to
recruit them to focal contacts and/or to induce their activa-
tion. In this study, we demonstrate that direct focal contact
targeting of Src, PI3K, Grb7 or Grb2 can induce signaling
pathways leading to increased cell migration or cell cycle pro-
gression. These results suggest that at least part of the role of
FAK interaction with these signaling molecules is to recruit
them to focal contacts.
FAK has been shown to play a role in the regulation of cell
migration as well as cell cycle progression [1,4]. Our ¢ndings
here suggest that distinct FAK signaling complexes with other
proteins are involved in the regulation of these two di¡erent
cellular processes. Targeting of Src, p85 or Grb7, but not
Grb2, to focal contacts stimulated cell migration (Fig. 4)
whereas focal contact targeting of Grb2, but not Src, p85 or
Grb7, increased cell cycle progression (Fig. 6). These results
are consistent with previous reports that FAK/PI3K [30] and
FAK/Grb7 complexes [24] play important roles in the regu-
lation of cell migration while the FAK/Grb2 complex is in-
volved in the activation of the Erk signaling pathway [25,34].
Stimulation of cell migration by each of the Src-FAT, p85-
FAT, or Grb7-FAT chimeric molecules suggested that FAK
complexes with these individual molecules may be su⁄cient to
stimulate cell migration under certain conditions. The mech-
anisms by which FAK complexes with each of these molecules
regulate cell migration are incompletely understood at
present. The formation of the Grb7 complex with FAK may
allow its direct phosphorylation by FAK, thus leading to the
activation of potential downstream pathways in cell migration
[29]. Association of p85 with FAK likely recruits the p110
catalytic subunit of PI3K to focal contacts where it may trig-
ger downstream signals for cell migration. Indeed, we found
that the p85-FAT chimeric molecule could associate with p110
as e¡ectively as p85 itself (data not shown). Interestingly,
overexpression of p85 itself did not promote cell migration
(data not shown), highlighting the crucial importance of focal
contact localization of the FAK/PI3K signaling complex.
The FAK/Src complex has been suggested to promote cell
migration through phosphorylation of p130cas and/or paxillin
[28,31]. Interestingly, Src-FAT induced tyrosine phosphoryla-
tion of paxillin, but not p130cas (Fig. 5). This may be due to
the lack of p130cas binding sites (P712 and P715) in the Src-
FAT chimeric molecule (Src fused to residues 890^1052 of
FAK), which was shown to be necessary for induction of
p130cas phosphorylation by the FAK/Src complex [28]. In
any case, these results suggest that the Src-FAT chimeric mol-
ecule might stimulate cell migration mainly through its e¡ects
on paxillin. They also suggest that direct targeting of Src to
focal contacts might lead to enhanced signaling in alternative
pathways (e.g. paxillin phosphorylation), thus alleviating the
requirement for p130cas phosphorylation in stimulation of
cell migration by FAK [28].
Stimulation of cell cycle progression by the Grb2-FAT chi-
mera suggested that the FAK/Grb2 complex and its subse-
quent activation of the Erk signaling pathway may play an
important role in the regulation of cell cycle progression by
FAK [17]. Our observation that the Src-FAT chimeric mole-
cule did not stimulate cell cycle progression is quite surprising,
however, because the FAK/Src complex has been suggested to
play a role in the regulation of both cell cycle progression and
cell migration [1,4]. The lack of stimulation of cell cycle pro-
gression by Src-FAT is not due to inactivation of Src kinase
activity upon its fusion with FAT or targeting to focal con-
tacts. Indeed, the chimeric molecule did promote cell migra-
Fig. 6. Regulation of cell cycle progression and Erk activation by
the chimeric molecules. A: NIH 3T3 cells were transfected with ex-
pression vectors encoding FAK or the chimeric molecules as indi-
cated. They were then analyzed for BrdU incorporation as described
in Section 2. The relative percentage of BrdU(+)/positively trans-
fected cells was normalized to cells transfected with FAT alone. Re-
sults show the mean+S.E.M. for at least three independent experi-
ments. B: NIH 3T3 cells were transfected with expression vectors
encoding His-tagged Erk and vectors encoding FAK, FAT, or the
chimeric molecules as indicated. The cells were suspended by trypsi-
nization and replated on FN for 20 min. His-Erk was precipitated
using the Ni beads and analyzed by Western blotting using anti-
phospho-Erk (top) or anti-Erk (bottom).
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tion (Fig. 4), induced paxillin phosphorylation (Fig. 5), and
exhibited comparable kinase activity as wild-type Src in in
vitro kinase assays (data not shown).
It is possible, however, that the Src-FAT chimeric molecule
could not phosphorylate the critical targets as the FAK/Src
complex in focal contacts, which were required for the stim-
ulation of cell cycle progression by FAK. Interestingly, Src-
FAT did not induce tyrosine phosphorylation of p130cas
whereas overexpression of FAK did (Fig. 5). As discussed
above, this may be due to the lack of p130cas binding sites
(P712 and P715) in the Src-FAT chimeric molecule. Tyrosine
phosphorylation of p130cas in cell adhesion has been sug-
gested to play a role in the stimulation of Erk activation
and cell cycle progression as measured by BrdU incorporation
[35,36]. It has also been suggested to regulate cell cycle pro-
gression through its coupling to the JNK signaling pathway
[37], although we did not detect any e¡ects of FAK or Src-
FAT on JNK pathway in our system (data not shown).
In addition, FAK/Grb2 complex formation has been shown
to depend on the phosphorylation of Y925 of FAK by its
associated Src [25]. Although Y925 is present in the FAT se-
quence of the Src-FAT chimera, it may not be accessible to
the active Src directly fused to this segment of FAK to allow
for phosphorylation and association of Grb2 to the chimera
at the focal contacts. Indeed, binding studies suggested that
the Src-FAT chimera was not associated with Grb2 (data not
shown). This might provide another explanation for the lack
of stimulation of cell cycle progression by the Src-FAT chi-
mera. This is supported by our observation that Grb2-FAT,
but not Src-FAT, reversed inhibition of Erk by FAT (Fig. 6).
It should also be noted that the above two possible interpre-
tations are not mutually exclusive. Indeed, phosphorylation of
p130cas and Y925 of FAK (thus formation of FAK/Grb2
complex) has been proposed to mediate Erk activation by
FAK in a cooperative manner [35]. Finally, we cannot exclude
the possibility that the lack of phosphorylation of other key
targets (other than or in addition to p130cas and Y925 of
FAK) by Src-FAT accounts for its lack of stimulation of
cell cycle progression.
In summary, we have shown that direct targeting of several
FAK-associated signaling molecules to focal contacts stimu-
lated cell migration or cell cycle progression, suggesting that
at least part of the role of FAK interaction with these signal-
ing molecules is to recruit them to focal contacts. Further-
more, our studies indicated that distinct FAK signaling com-
plexes are involved in the regulation of cell migration vs. cell
cycle progression. These studies provided further insights into
the mechanisms by which integrin signaling through FAK
regulates cell migration and cell cycle progression.
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